Cornerstone Capital Management Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-11,954
| Closed | -$751K | – | 1380 |
|
2016
Q1 | $751K | Sell |
11,954
-4,422
| -27% | -$278K | 0.01% | 960 |
|
2015
Q4 | $1.54M | Sell |
16,376
-6,575
| -29% | -$619K | 0.01% | 799 |
|
2015
Q3 | $1.84M | Buy |
22,951
+20,668
| +905% | +$1.66M | 0.02% | 743 |
|
2015
Q2 | $274K | Sell |
2,283
-33,405
| -94% | -$4.01M | ﹤0.01% | 1137 |
|
2015
Q1 | $3.73M | Buy |
35,688
+24,150
| +209% | +$2.52M | 0.03% | 516 |
|
2014
Q4 | $1.12M | Buy |
+11,538
| New | +$1.12M | 0.01% | 862 |
|